Skip to content
Disclosery

Carlyle Group Inc.

Follow

13F filer, CIK 1527166, WASHINGTON, DC

Carlyle Group Inc. reported $10,000,861,951 across 19 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-07. Its ten largest share positions make up 99.94% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000898432-26-000602

Period
2026-06-30
Reported value
$10B
Holdings
19
Top 10 weight
99.94%
New
3
Sold out
4

Part of the filer group Carlyle Group Inc.

How groups are built

Largest buys vs the previous quarter

SecurityShares changeApprox. value
SPWRadded+1,910,592$1.31M
REPXnew+16,092$530K
NBISnew+1,846$510K
METCnew+21,743$288K
HOODadded+1,357$136K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
QTTBreduced-1,042,378-$13.3M
CUBEexited-220,500-$8.08M
HTFLexited-20,438-$497K
SYREexited-9,620-$485K
XCURexited-56,328-$240K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0000898432-26-000602, largest first. % of portfolio is the value over $10,000,861,951, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
MDLNMEDLINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 215,303,036 shares; 2026Q1: 187,083,713 shares; 2026Q2: 187,083,713 shares 187,083,713$7.38B73.78%0Timeline
SAROSTANDARDAERO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 6,675,862 shares; 2025Q1: 134,352,830 shares; 2025Q2: 152,673,891 shares; 2025Q3: 152,673,891 shares; 2025Q4: 152,673,891 shares; 2026Q1: 84,587,035 shares; 2026Q2: 84,587,035 shares 84,587,035$2.53B25.3%0Timeline
PHATPHATHOM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 3,496,808 shares; 2024Q4: 3,496,808 shares; 2025Q1: 3,496,808 shares; 2025Q2: 3,496,808 shares; 2025Q3: 3,496,808 shares; 2025Q4: 3,496,808 shares; 2026Q1: 3,496,808 shares; 2026Q2: 3,496,808 shares 3,496,808$37.9M0.38%0Timeline
INVHINVITATION HOMES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 477,500 shares; 2024Q4: 477,500 shares; 2025Q1: 477,500 shares; 2025Q2: 477,500 shares; 2025Q3: 477,500 shares; 2025Q4: 664,100 shares; 2026Q1: 664,100 shares; 2026Q2: 662,900 shares 662,900$20M0.2%-1,200Timeline
PONYPONY AI INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 2,362,447 shares; 2025Q1: 2,362,447 shares; 2025Q2: 2,362,447 shares; 2025Q3: 2,362,447 shares; 2025Q4: 2,362,447 shares; 2026Q1: 2,362,447 shares; 2026Q2: 2,362,447 shares 2,362,447$16.4M0.16%0Timeline
GETYGETTY IMAGES HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 9,212,799 shares; 2024Q4: 8,684,599 shares; 2025Q1: 6,234,252 shares; 2025Q2: 6,234,252 shares; 2025Q3: 6,234,252 shares; 2025Q4: 6,234,252 shares; 2026Q1: 6,234,252 shares; 2026Q2: 6,234,252 shares 6,234,252$5.36M0.05%0Timeline
SPRBSPRUCE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 2,896,518 shares; 2025Q4: 38,620 shares; 2026Q1: 38,620 shares; 2026Q2: 38,620 shares 38,620$2.09M0.02%0Timeline
SPWRSUNPOWER INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 4,901,340 shares; 2024Q4: 1,984,619 shares; 2025Q1: 1,984,508 shares; 2025Q2: 1,587,467 shares; 2025Q3: 1,258,970 shares; 2025Q4: 433,158 shares; 2026Q1: 433,158 shares; 2026Q2: 2,343,750 shares 2,343,750$1.61M0.02%+1,910,592Timeline
ACETADICET BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 184,295 shares; 2026Q1: 184,295 shares; 2026Q2: 184,295 shares 184,295$1.59M0.02%0Timeline
FWRDFORWARD AIR CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 107,214 shares; 2025Q3: 107,214 shares; 2025Q4: 107,214 shares; 2026Q1: 107,214 shares; 2026Q2: 107,214 shares 107,214$1.45M0.01%0Timeline
OKURONKURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 269,895 shares; 2025Q1: 269,895 shares; 2025Q2: 269,895 shares; 2025Q3: 269,895 shares; 2025Q4: 269,895 shares; 2026Q1: 269,895 shares; 2026Q2: 269,895 shares 269,895$1.23M0.01%0Timeline
DNUTKRISPY KREME INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 340,748 shares; 2024Q4: 340,748 shares; 2025Q1: 340,748 shares; 2025Q2: 340,748 shares; 2025Q3: 340,748 shares; 2025Q4: 340,748 shares; 2026Q1: 340,748 shares; 2026Q2: 340,748 shares 340,748$1.2M0.01%0Timeline
QTTBQ32 BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,102,741 shares; 2024Q4: 1,102,741 shares; 2025Q1: 1,102,741 shares; 2025Q2: 1,102,741 shares; 2025Q3: 1,102,741 shares; 2025Q4: 1,102,741 shares; 2026Q1: 1,102,741 shares; 2026Q2: 60,363 shares 60,363$769K0.01%-1,042,378Timeline
REPXRILEY EXPLORATION PERMIAN INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 9,880 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 16,092 shares 16,092$530K0.01%newTimeline
NBISNEBIUS GROUP N.V.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,846 shares 1,846$510K0.01%newTimeline
HOODROBINHOOD MKTS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 6,242 shares; 2025Q1: not reported; 2025Q2: 2,497 shares; 2025Q3: not reported; 2025Q4: 3,376 shares; 2026Q1: 3,376 shares; 2026Q2: 4,733 shares 4,733$475K<0.01%+1,357Timeline
JSPRJASPER THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,066,189 shares; 2024Q4: 1,066,189 shares; 2025Q1: 1,066,189 shares; 2025Q2: 1,066,189 shares; 2025Q3: 1,066,189 shares; 2025Q4: 1,066,189 shares; 2026Q1: 1,066,189 shares; 2026Q2: 1,066,189 shares 1,066,189$449K<0.01%0Timeline
NABLN-ABLE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 93,732 shares; 2024Q4: 93,732 shares; 2025Q1: 93,732 shares; 2025Q2: 93,732 shares; 2025Q3: 93,732 shares; 2025Q4: 93,732 shares; 2026Q1: 93,732 shares; 2026Q2: 93,732 shares 93,732$344K<0.01%0Timeline
METCRAMACO RES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 19,569 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 21,743 shares 21,743$288K<0.01%newTimeline

Sold out in Q2 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
CUBECUBESMART220,500$8.08Mshares
HTFLHEARTFLOW INC20,438$497Kshares
SYRESPYRE THERAPEUTICS INC9,620$485Kshares
XCUREXICURE INC56,328$240Kshares

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000898432-26-000602 base2026-08-07acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0000898432-26-000602 Quarter ended 2026-06-302026-08-07acceptance time not in the bulk data set
13F-HR 0000898432-26-000339 Quarter ended 2026-03-312026-05-08acceptance time not in the bulk data set
13F-HR 0000898432-26-000105 Quarter ended 2025-12-312026-02-13acceptance time not in the bulk data set
13F-HR 0000898432-25-000873 Quarter ended 2025-09-302025-11-07acceptance time not in the bulk data set
13F-HR 0000898432-25-000575 Quarter ended 2025-06-302025-08-08acceptance time not in the bulk data set
13F-HR 0000898432-25-000328 Quarter ended 2025-03-312025-05-09acceptance time not in the bulk data set
13F-HR 0000898432-25-000122 Quarter ended 2024-12-312025-02-13acceptance time not in the bulk data set
13F-HR 0000898432-24-000887 Quarter ended 2024-09-302024-11-08acceptance time not in the bulk data set
13F-HR 0000898432-24-000692 Quarter ended 2024-06-302024-08-09acceptance time not in the bulk data set
13F-HR 0000898432-24-000359 Quarter ended 2024-03-312024-05-03acceptance time not in the bulk data set
13F-HR 0000898432-24-000085 Quarter ended 2023-12-312024-02-02acceptance time not in the bulk data set
13F-HR 0000898432-23-000761 Quarter ended 2023-09-302023-11-03acceptance time not in the bulk data set
13F-HR 0000898432-23-000571 Quarter ended 2023-06-302023-08-04acceptance time not in the bulk data set
13F-HR 0000898432-23-000256 Quarter ended 2023-03-312023-05-05acceptance time not in the bulk data set
13F-HR 0000898432-23-000082 Quarter ended 2022-12-312023-02-10acceptance time not in the bulk data set
13F-HR 0001567619-22-019566 Quarter ended 2022-09-302022-11-10acceptance time not in the bulk data set
13F-HR 0001567619-22-015856 Quarter ended 2022-06-302022-08-12acceptance time not in the bulk data set
13F-HR 0001567619-22-010546 Quarter ended 2022-03-312022-05-13acceptance time not in the bulk data set
13F-HR 0001567619-22-003595 Quarter ended 2021-12-312022-02-11acceptance time not in the bulk data set
13F-HR 0001567619-21-020081 Quarter ended 2021-09-302021-11-12acceptance time not in the bulk data set
13F-HR 0001567619-21-015299 Quarter ended 2021-06-302021-08-12acceptance time not in the bulk data set
13F-HR 0001567619-21-010219 Quarter ended 2021-03-312021-05-14acceptance time not in the bulk data set
13F-HR 0001567619-21-003577 Quarter ended 2020-12-312021-02-12acceptance time not in the bulk data set
13F-HR 0001567619-20-019616 Quarter ended 2020-09-302020-11-13acceptance time not in the bulk data set
13F-HR 0001567619-20-015131 Quarter ended 2020-06-302020-08-13acceptance time not in the bulk data set
13F-HR 0001567619-20-009844 Quarter ended 2020-03-312020-05-13acceptance time not in the bulk data set
13F-HR 0001567619-20-003389 Quarter ended 2019-12-312020-02-13acceptance time not in the bulk data set
13F-HR 0001567619-19-021213 Quarter ended 2019-09-302019-11-13acceptance time not in the bulk data set
13F-HR 0001567619-19-016577 Quarter ended 2019-06-302019-08-13acceptance time not in the bulk data set
13F-HR 0001567619-19-010632 Quarter ended 2019-03-312019-05-13acceptance time not in the bulk data set
13F-HR/A 0001567619-19-010614 Quarter ended 2018-06-302019-05-13acceptance time not in the bulk data set
13F-HR/A 0001567619-19-010623 Quarter ended 2018-12-312019-05-13acceptance time not in the bulk data set
13F-HR/A 0001567619-19-010621 Quarter ended 2018-09-302019-05-13acceptance time not in the bulk data set
13F-HR 0001567619-19-004302 Quarter ended 2018-12-312019-02-14acceptance time not in the bulk data set
13F-HR 0001567619-18-005853 Quarter ended 2018-09-302018-11-13acceptance time not in the bulk data set
13F-HR 0001567619-18-001126 Quarter ended 2018-06-302018-08-14acceptance time not in the bulk data set
13F-HR 0001140361-18-023418 Quarter ended 2018-03-312018-05-14acceptance time not in the bulk data set
13F-HR 0001140361-18-008376 Quarter ended 2017-12-312018-02-14acceptance time not in the bulk data set
13F-HR 0001140361-17-042118 Quarter ended 2017-09-302017-11-13acceptance time not in the bulk data set
13F-HR 0001140361-17-031413 Quarter ended 2017-06-302017-08-11acceptance time not in the bulk data set
13F-HR 0001140361-17-019801 Quarter ended 2017-03-312017-05-11acceptance time not in the bulk data set
13F-HR 0001140361-17-005823 Quarter ended 2016-12-312017-02-10acceptance time not in the bulk data set
13F-HR 0001140361-16-086541 Quarter ended 2016-09-302016-11-14acceptance time not in the bulk data set
13F-HR 0001140361-16-075717 Quarter ended 2016-06-302016-08-10acceptance time not in the bulk data set
13F-HR/A 0001140361-16-065225 Quarter ended 2015-12-312016-05-13acceptance time not in the bulk data set
13F-HR 0001140361-16-065228 Quarter ended 2016-03-312016-05-13acceptance time not in the bulk data set
13F-HR 0001140361-16-052375 Quarter ended 2015-12-312016-02-12acceptance time not in the bulk data set
13F-HR 0001140361-15-041187 Quarter ended 2015-09-302015-11-13acceptance time not in the bulk data set
13F-HR 0001140361-15-032052 Quarter ended 2015-06-302015-08-14acceptance time not in the bulk data set
13F-HR/A 0001140361-15-027433 Quarter ended 2014-12-312015-07-13acceptance time not in the bulk data set
13F-HR/A 0001140361-15-027432 Quarter ended 2014-12-312015-07-13acceptance time not in the bulk data set
13F-HR 0001140361-15-020305 Quarter ended 2015-03-312015-05-15acceptance time not in the bulk data set
13F-HR 0001140361-15-007114 Quarter ended 2014-12-312015-02-17acceptance time not in the bulk data set
13F-HR/A 0001140361-15-003009 Quarter ended 2013-09-302015-01-28acceptance time not in the bulk data set
13F-HR/A 0001140361-15-003010 Quarter ended 2013-12-312015-01-28acceptance time not in the bulk data set
13F-HR/A 0001140361-15-003012 Quarter ended 2014-06-302015-01-28acceptance time not in the bulk data set
13F-HR/A 0001140361-15-003011 Quarter ended 2014-03-312015-01-28acceptance time not in the bulk data set
13F-HR 0001140361-14-042066 Quarter ended 2014-09-302014-11-14acceptance time not in the bulk data set
13F-HR 0001140361-14-032626 Quarter ended 2014-06-302014-08-14acceptance time not in the bulk data set
13F-HR 0001140361-14-021149 Quarter ended 2014-03-312014-05-15acceptance time not in the bulk data set
13F-HR 0001140361-14-007511 Quarter ended 2013-12-312014-02-14acceptance time not in the bulk data set
13F-HR 0001140361-13-042641 Quarter ended 2013-09-302013-11-14acceptance time not in the bulk data set
13F-HR/A 0001140361-13-033434 Quarter ended 2013-03-312013-08-19acceptance time not in the bulk data set
13F-HR 0001140361-13-032525 Quarter ended 2013-06-302013-08-14acceptance time not in the bulk data set